ASP-1001
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameASP-1001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsphelia Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesThe University Of ChicagoAsphelia Pharmaceuticals
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A